SCHEMBL845176

SCHEMBL845176

Cn1ccnc1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3nccn3C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RHOC P08134 1/20 0.42
RHOA P61586 1/20 0.42
NPC1 O15118 1/20 0.42
PABPC1 P11940 1/20 0.42
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.41
MAPK1 P28482 1/20 0.41
CNR2 P34972 1/20 0.41
EP300 Q09472 1/20 0.41
CREBBP Q92793 1/20 0.41
MAPT P10636 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845260 0.89 CYP2C9 (0.36) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL845042 0.82 ALDH1A1 (0.47) CYP2C9CYP2C19NPC1PABPC1ALDH1A1
SCHEMBL14648056 0.81 NPC1 (0.41) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL845282 0.81 CYP2C9 (0.47) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL873200 0.80 RHOC (0.48) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL844934 0.79 RHOC (0.51) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL845341 0.79 CYP2C9 (0.43) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL845405 0.79 TRPV1 (0.46) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL845048 0.79 DGAT1 (0.50) CYP2C9CYP2C19RHOCRHOANPC1
SCHEMBL844980 0.78 ALDH1A1 (0.45) CYP2C9CYP2C19RHOCRHOAPABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed